{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:13:47Z","timestamp":1791947627892,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00277-017-3218-0","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T16:30:55Z","timestamp":1515515455000},"page":"669-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-7769","authenticated-orcid":false,"given":"Andrea","family":"Janikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbynek","family":"Bortlicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit","family":"Campr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Kopalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Benesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Hamouzova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Belada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit","family":"Prochazka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pytlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Vokurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pirnos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Duras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Mocikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Trneny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"issue":"4","key":"3218_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C, Bryon PA, Coiffier B (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15(4):1587\u20131594. https:\/\/doi.org\/10.1200\/JCO.1997.15.4.1587","journal-title":"J Clin Oncol"},{"issue":"17","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","volume":"25","author":"S Montoto","year":"2007","unstructured":"Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Waters R, Rohatiner AZS, Lister TA (2007) Risk and clinical implications of transformation follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 25(17):2426\u20132433. https:\/\/doi.org\/10.1200\/JCO.2006.09.3260","journal-title":"J Clin Oncol"},{"issue":"32","key":"3218_CR3","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, Sehn LH, Shenkier TN, Gascoyne RD, Connors JM (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma. J Clin Oncol 26(32):5165\u20135169. https:\/\/doi.org\/10.1200\/JCO.2008.16.0283","journal-title":"J Clin Oncol"},{"issue":"4","key":"3218_CR4","first-page":"953","volume":"20","author":"NJ Morley","year":"2008","unstructured":"Morley NJ, Evans LS, Goepel J, Hancock BW (2008) Transformed follicular lymphoma: the 25-year experience of a UK provincial lymphoma treatment centre. Oncol Rep 20(4):953\u2013956","journal-title":"Oncol Rep"},{"key":"3218_CR5","unstructured":"Swerdlow SH, Campo E, Harris NL et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on cancer (IARC); 4th Edition, Lyon 2008"},{"issue":"6","key":"3218_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2013-03-491514","volume":"122","author":"D Tan","year":"2013","unstructured":"Tan D, Horning SJ, Hoppe RT, Levy R, Rosenberg SA, Sigal BM, Warnke RA, Natkunam Y, Han SS, Yuen A, Plevritis SK, Advani RH (2013) Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 122(6):981\u2013987. https:\/\/doi.org\/10.1182\/blood-2013-03-491514","journal-title":"Blood"},{"issue":"2","key":"3218_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","volume":"157","author":"A Conconi","year":"2012","unstructured":"Conconi A, Ponzio C, Lobetti-Bodoni C, Motta M, Rancoita PMV, Stathis A, Moccia AA, Mazzucchelli L, Bertoni F, Ghielmini M, Cavalli F, Zucca E (2012) Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Hematol 157(2):188\u2013196. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09054.x","journal-title":"Br J Hematol"},{"issue":"26","key":"3218_CR8","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR, Syrbu SI, Slager SL, Thompson CA, Inwards DJ, Johnston PB, Colgan JP, Witzig TE, Habermann TM, Cerhan JR (2013) Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol 31(26):3272\u20133278. https:\/\/doi.org\/10.1200\/JCO.2012.48.3990","journal-title":"J Clin Oncol"},{"issue":"11","key":"3218_CR9","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on no Hodgkin\u2019s disease staging classification. Cancer Res 31(11):1860\u20131861","journal-title":"Cancer Res"},{"issue":"3","key":"3218_CR10","first-page":"146","volume":"23","author":"A Sykorova","year":"2010","unstructured":"Sykorova A, Belada D, Smolej L et al (2010) Staging of non-Hodgkin\u2019s lymphoma\u2014recommendations of the Czech Lymphoma Study Group. Klin Onkol 23(3):146\u2013154","journal-title":"Klin Onkol"},{"issue":"5","key":"3218_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","volume":"83","author":"MA Shipp","year":"1994","unstructured":"Shipp MA (1994) Prognostic factors in aggressive non-Hodgkin\u2019s lymphoma: who has \u201chigh-risk\u201d disease? Blood 83(5):1165\u20131173","journal-title":"Blood"},{"issue":"5","key":"3218_CR12","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chanabhai M et al (2007) The Revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with DLBCL treated with R-CHOP. Blood 109(5):1857\u20131861. https:\/\/doi.org\/10.1182\/blood-2006-08-038257","journal-title":"Blood"},{"issue":"5","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P et al (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258\u20131265. https:\/\/doi.org\/10.1182\/blood-2003-12-4434","journal-title":"Blood"},{"key":"3218_CR14","doi-asserted-by":"crossref","unstructured":"Prochazka V, Papajik T, Janikova A et al. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Group Database. Leuk Lymphoma 2016; Sep 25: 1\u201313","DOI":"10.1080\/10428194.2016.1213834"},{"issue":"2","key":"3218_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/annonc\/mds433","volume":"24","author":"P Bains","year":"2013","unstructured":"Bains P, Al Tourah A, Cambell BA et al (2013) Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. Ann Oncol 24(2):428\u2013432. https:\/\/doi.org\/10.1093\/annonc\/mds433","journal-title":"Ann Oncol"},{"issue":"7","key":"3218_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, Friedberg JW, Bartlett NL (2015) Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood 126(7):851\u2013857. https:\/\/doi.org\/10.1182\/blood-2015-01-621375","journal-title":"Blood"},{"issue":"22","key":"3218_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","volume":"34","author":"C Sarkozy","year":"2016","unstructured":"Sarkozy C, Trneny M, Xerri L, Wickham N, Feugier P, Leppa S, Brice P, Soubeyran P, Gomes da Silva M, Mounier C, Offner F, Dupuis J, Caballero D, Canioni D, Paula M, Delarue R, Zachee P, Seymour J, Salles G, Tilly H (2016) Risk of transformation and outcome for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial. J Clin Oncol 34(22):2575\u20132582. https:\/\/doi.org\/10.1200\/JCO.2015.65.7163","journal-title":"J Clin Oncol"},{"issue":"3","key":"3218_CR18","first-page":"783","volume":"95","author":"M Federico","year":"2000","unstructured":"Federico M, Vitolo U, Zinzani PL, Chisesi T, Cl\u00f2 V, Bellesi G, Magagnoli M, Liberati M, Boccomini C, Niscola P, Pavone V, Cuneo A, Santini G, Brugiatelli M, Baldini L, Rigacci L, Resegotti L (2000) Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood 95(3):783\u2013789","journal-title":"Blood"},{"issue":"4","key":"3218_CR19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjh.12570","volume":"163","author":"M Ban-Hoefen","year":"2013","unstructured":"Ban-Hoefen M, Vanderplas A, Al C-T et al (2013) Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcome database. Br J Hematology 163(4):487\u2013495","journal-title":"Br J Hematology"},{"issue":"6","key":"3218_CR20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00277-013-1991-y","volume":"93","author":"HR Guirguis","year":"2014","unstructured":"Guirguis HR, Cheung MC, Piliotis E, Spaner D, Berinstein NL, Imrie K, Zhang L, Buckstein R (2014) Survival of patients with transformed lymphoma in the rituximab era. Ann Hematol 93(6):1007\u20131014. https:\/\/doi.org\/10.1007\/s00277-013-1991-y","journal-title":"Ann Hematol"},{"issue":"6","key":"3218_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3109\/0284186X.2014.978367","volume":"54","author":"G Hedstr\u00f6m","year":"2015","unstructured":"Hedstr\u00f6m G, Hagberg P, Jerkeman M et al (2015) The impact of age on survival of diffuse large B-cell lymphoma\u2014a population based study. Acta Oncol 54(6):916\u2013923. https:\/\/doi.org\/10.3109\/0284186X.2014.978367","journal-title":"Acta Oncol"},{"issue":"8","key":"3218_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/ajh.24401","volume":"91","author":"C Nabhan","year":"2016","unstructured":"Nabhan C, Zhou X, Day BM, Dawson K, Zelenetz AD, Friedberg JW, Cerhan JR, Link BK, Flowers CR (2016) Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States. Am J Hematol 91(8):770\u2013775. https:\/\/doi.org\/10.1002\/ajh.24401","journal-title":"Am J Hematol"},{"issue":"12","key":"3218_CR23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00277-016-2800-1","volume":"95","author":"S Yuda","year":"2016","unstructured":"Yuda S, Maruyama D, Maeshima AM, Makita S, Kitahara H, Miyamoto K, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Tajima K, Taniguchi H, Tobinai K (2016) Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Ann Hematol 95(12):2017\u20132022. https:\/\/doi.org\/10.1007\/s00277-016-2800-1","journal-title":"Ann Hematol"},{"issue":"6","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","volume":"94","author":"K Lerch","year":"2015","unstructured":"Lerch K, Meyer AH, Stroux A, Hirt C, Keller U, Viardot A, Marks R, Schreiber S, Pezzutto A, Scholz CW (2015) Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicenter analysis. Ann Hematol 94(6):981\u2013988. https:\/\/doi.org\/10.1007\/s00277-015-2303-5","journal-title":"Ann Hematol"},{"issue":"3","key":"3218_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/bjh.13316","volume":"169","author":"TC El-Galaly","year":"2015","unstructured":"El-Galaly TC, Bilgrau AE, de Nully BP et al (2015) A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait. Br J Hematol 169(3):435\u2013444. https:\/\/doi.org\/10.1111\/bjh.13316","journal-title":"Br J Hematol"},{"issue":"4","key":"3218_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","volume":"15","author":"KM Ardeshna","year":"2014","unstructured":"Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens L, Pocock CFE, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J, Ferhanoglu B, Bradstock K, Linch DC (2014 Apr) Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol 15(4):424\u2013435. https:\/\/doi.org\/10.1016\/S1470-2045(14)70027-0","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3218-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T10:51:43Z","timestamp":1603623103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3218-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3218-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}